# Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma

> **NCT06606301** · — · COMPLETED · sponsor: **Combined Military Hospital, Pakistan** · enrollment: 61 (actual)

## Conditions studied

- Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer

## Interventions

- **DIAGNOSTIC_TEST:** BioSB EGFR antibody

## Key facts

- **NCT ID:** NCT06606301
- **Lead sponsor:** Combined Military Hospital, Pakistan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-26
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-12-28
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06606301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06606301, "Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06606301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*